Mesenchymal stem cell (MSC) transplantation, as an alternative strategy to orthotopic liver
transplantation, has been evaluated for treating end-stage liver disease. Although the …

Gastric cancer (GC) is the most common gastrointestinal malignant tumor, and distant
metastasis is a critical factor in the prognosis of patients with GC. Understanding the …

Thrombosis is one of the major global causes of morbidity and mortality, and predicting the
risk of thrombotic and cardiovascular complications remains one of the key challenges in …

Cells are known to continuously remodel their local extracellular matrix (ECM) and in a
reciprocal way, they can also respond to mechanical and biochemical properties of their …

Background Increased levels of plasminogen activator inhibitor-1 (PAI-1) in tumors have
been found to correlate with poor clinical outcomes in patients with cancer. Although …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of cancer and has a poor
prognosis. Patients with PDAC are at high risk of developing thromboembolic events, which …

Background Colorectal cancer (CRC) is a common cancer and has a poor prognosis. The
coagulation system and fibrinolysis system are closely related to the progression of …

The clinical course for patients with neuroendocrine neoplasms (NENs) ranges from
indolent to highly aggressive. Noninvasive tools to improve prognostication and guide …

Various species of non-coding RNAs (ncRNAs) may act as functional molecules regulating
diverse biological processes. In cancer cell biology, ncRNAs include RNAs that regulate the …

Metastatic castration-resistant prostate cancer (mCRPC) is associated with a poor prognosis
and remains an incurable fatal disease. Therefore, the identification of molecular markers …